BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30622570)

  • 21. Generation of novel Il2rg-knockout mice with clustered regularly interspaced short palindromic repeats (CRISPR) and Cas9.
    Byambaa S; Uosaki H; Hara H; Nagao Y; Abe T; Shibata H; Nureki O; Ohmori T; Hanazono Y
    Exp Anim; 2020 Apr; 69(2):189-198. PubMed ID: 31801915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation analysis of IL2RG in human X-linked severe combined immunodeficiency.
    Puck JM; Pepper AE; Henthorn PS; Candotti F; Isakov J; Whitwam T; Conley ME; Fischer RE; Rosenblatt HM; Small TN; Buckley RH
    Blood; 1997 Mar; 89(6):1968-77. PubMed ID: 9058718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intact B-Cell Signaling and Function With Host B-Cells 47 Years After Transplantation for X-SCID.
    Deal C; Thauland TJ; Stiehm ER; Garcia-Lloret MI; Butte MJ
    Front Immunol; 2020; 11():415. PubMed ID: 32265911
    [No Abstract]   [Full Text] [Related]  

  • 24. A novel X-linked mutation in IL2RG associated with early-onset inflammatory bowel disease: a case report of twin brothers.
    Rayzan E; Sadeghalvad M; Shahkarami S; Zoghi S; Aryan Z; Mahdaviani SA; Boztug K; Rezaei N
    J Med Case Rep; 2023 Jul; 17(1):307. PubMed ID: 37461086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency.
    Pepper AE; Buckley RH; Small TN; Puck JM
    Am J Hum Genet; 1995 Sep; 57(3):564-71. PubMed ID: 7668284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model.
    Alzubi J; Pallant C; Mussolino C; Howe SJ; Thrasher AJ; Cathomen T
    Sci Rep; 2017 Sep; 7(1):12475. PubMed ID: 28963568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A reversion of an IL2RG mutation in combined immunodeficiency providing competitive advantage to the majority of CD8+ T cells.
    Kuijpers TW; van Leeuwen EM; Barendregt BH; Klarenbeek P; aan de Kerk DJ; Baars PA; Jansen MH; de Vries N; van Lier RA; van der Burg M
    Haematologica; 2013 Jul; 98(7):1030-8. PubMed ID: 23403317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. X-linked severe combined immunodeficiency due to a novel mutation complicated with hemophagocytic lymphohistiocytosis and presented with invagination: A case report.
    Patiroglu T; Haluk Akar H; van den Burg M; Unal E; Akyildiz BN; Tekerek NU; Yilmaz E
    Eur J Microbiol Immunol (Bp); 2014 Sep; 4(3):174-6. PubMed ID: 25215194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transplantation of human cells into Interleukin-2 receptor gamma gene knockout pigs under several conditions.
    Hasegawa K; Nakano K; Nagaya M; Watanabe M; Uchikura A; Matsunari H; Umeyama K; Kobayashi E; Nagashima H
    Regen Ther; 2022 Dec; 21():62-72. PubMed ID: 35765545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1.
    Puck JM; Deschênes SM; Porter JC; Dutra AS; Brown CJ; Willard HF; Henthorn PS
    Hum Mol Genet; 1993 Aug; 2(8):1099-104. PubMed ID: 8401490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient detection of thirty-seven new IL2RG mutations in human X-linked severe combined immunodeficiency.
    Niemela JE; Puck JM; Fischer RE; Fleisher TA; Hsu AP
    Clin Immunol; 2000 Apr; 95(1 Pt 1):33-8. PubMed ID: 10794430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Severe combined immunodeficiency in Serbia and Montenegro between years 1986 and 2010: a single-center experience.
    Pasic S; Vujic D; Veljković D; Slavkovic B; Mostarica-Stojkovic M; Minic P; Minic A; Ristic G; Giliani S; Villa A; Sobacchi C; Lilić D; Abinun M
    J Clin Immunol; 2014 Apr; 34(3):304-8. PubMed ID: 24481607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational landscape of severe combined immunodeficiency patients from Turkey.
    Firtina S; Yin Ng Y; Hatirnaz Ng O; Kiykim A; Aydiner E; Nepesov S; Camcioglu Y; Sayar EH; Reisli I; Torun SH; Cogurlu T; Uygun D; Simsek IE; Kaya A; Cipe F; Cagdas D; Yucel E; Cekic S; Uygun V; Baris S; Ozen A; Ozbek U; Sayitoglu M
    Int J Immunogenet; 2020 Dec; 47(6):529-538. PubMed ID: 32445296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical characteristics and mutation analysis of X-linked severe combined immunodeficiency in China.
    Zhang C; Zhang ZY; Wu JF; Tang XM; Yang XQ; Jiang LP; Zhao XD
    World J Pediatr; 2013 Feb; 9(1):42-7. PubMed ID: 22105576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel
    Rutkowska-Zapała M; Szaflarska A; Kluczewska A; Ciȩciwa J; Plewka J; Michalska A; Siedlar M
    Front Pediatr; 2022; 10():858166. PubMed ID: 35498802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Il2rg gene-targeted severe combined immunodeficiency pigs.
    Suzuki S; Iwamoto M; Saito Y; Fuchimoto D; Sembon S; Suzuki M; Mikawa S; Hashimoto M; Aoki Y; Najima Y; Takagi S; Suzuki N; Suzuki E; Kubo M; Mimuro J; Kashiwakura Y; Madoiwa S; Sakata Y; Perry ACF; Ishikawa F; Onishi A
    Cell Stem Cell; 2012 Jun; 10(6):753-758. PubMed ID: 22704516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel splice donor mutation in
    Zhang X; Jiang W; Jin Z; Wang X; Song X; Huang S; Zhang M; Lu H
    Front Oncol; 2023; 13():1282678. PubMed ID: 37901335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
    Puck JM; Pepper AE; Bédard PM; Laframboise R
    J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred.
    O'Marcaigh AS; Puck JM; Pepper AE; De Santes K; Cowan MJ
    J Clin Immunol; 1997 Jan; 17(1):29-33. PubMed ID: 9049783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of checkpoints in human T-cell development using severe combined immunodeficiency stem cells.
    Wiekmeijer AS; Pike-Overzet K; IJspeert H; Brugman MH; Wolvers-Tettero IL; Lankester AC; Bredius RG; van Dongen JJ; Fibbe WE; Langerak AW; van der Burg M; Staal FJ
    J Allergy Clin Immunol; 2016 Feb; 137(2):517-526.e3. PubMed ID: 26441229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.